
Europe Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Country and Growth Forecast, 2024 - 2031
Description
Europe Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Country and Growth Forecast, 2024 - 2031
The Europe Vendor Neutral Archive (VNA) & PACS Market would witness market growth of 8.9% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $561.3 million by 2031. The UK market is exhibiting a CAGR of 8.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 9.8% during (2024 - 2031).
Both VNA and PACS systems can integrate various imaging modalities, such as CT scans, MRIs, X-rays, and ultrasounds. This multimodal data integration guarantees that various imaging techniques are stored uniformly, facilitating comprehensive analysis and comparison. It enhances diagnostic accuracy by providing a holistic view of a patient's imaging data.
VNA and PACS systems are crucial in enabling remote diagnostics and telemedicine services. They allow radiologists and other healthcare professionals to access and interpret imaging data from remote locations, supporting teleradiology and telemedicine consultations. This capability is especially beneficial in rural or underserved areas with limited access to specialized diagnostic services. VNA and PACS systems serve as valuable resources for research and educational purposes.
The expansion of the healthcare sector in Germany is significantly influencing the vendor neutral archive (VNA) and PACS market. With an impressive economic footprint of EUR 775 billion, accounting for approximately 12% of the nation's GDP, Germany’s healthcare system is one of the largest in Europe, creating a robust demand for advanced medical imaging solutions and data management technologies. A notable component of this digital transformation is the government's allocation of €1.67 billion under the National Recovery and Resilience Program (NRRP) for electronic medical records (EMR) and e-health technology infrastructure. With 35% of the population currently utilizing EMR systems across 21 regions, the need for efficient data management and interoperability becomes paramount. VNA solutions enable healthcare providers to store, manage, and share medical imaging data from various sources in a standardized format, ensuring seamless access to patient information. Therefore, the expansion of Germany's healthcare sector and rising digitalization in Italy’s healthcare is fostering a conducive environment for the growth of the market.
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on Application, the market is segmented into Cardiology, Orthopedic, Oncology, Neurology, Obstetrics & Gynecology, and Others. Based on Modality, the market is segmented into Computed Tomography, Mammography, MRI, Ultrasound, X-Rays, and PET. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Hyland Software, Inc.
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- Fujifilm Holdings Corporation
- IBM Corporation
- Carestream Health, Inc. (Onex Corporation)
- Novarad Enterprise Healthcare Solutions
- Canon, Inc. (Canon Medical Systems Corporation)
- INFINITT Healthcare Co. Ltd.
By Product Type
- VNA
- Multi-Department VNA
- Department VNA
- Multi-Site VNA
- PACS
- Multi-Department PACS
- Department PACS
- Multi-Site PACS
- Independent Vendor
- Third-party Vendor
- On-Premise
- Cloud-Based
- Hybrid Model
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Cardiology
- Orthopedic
- Oncology
- Neurology
- Obstetrics & Gynecology
- Others
- Computed Tomography
- Mammography
- MRI
- Ultrasound
- X-Rays
- PET
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
216 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Vendor Neutral Archive (VNA) & PACS Market, by Product Type
- 1.4.2 Europe Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
- 1.4.3 Europe Vendor Neutral Archive (VNA) & PACS Market, by Deployment
- 1.4.4 Europe Vendor Neutral Archive (VNA) & PACS Market, by End User
- 1.4.5 Europe Vendor Neutral Archive (VNA) & PACS Market, by Application
- 1.4.6 Europe Vendor Neutral Archive (VNA) & PACS Market, by Modality
- 1.4.7 Europe Vendor Neutral Archive (VNA) & PACS Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2023
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug – 2024, Feb) Leading Players
- 4.5 Porter Five Forces Analysis
- Chapter 5. Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 5.1 Europe VNA Market by Country
- 5.2 Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 5.2.1 Europe Multi-Department VNA Market by Country
- 5.2.2 Europe Department VNA Market by Country
- 5.2.3 Europe Multi-Site VNA Market by Country
- 5.3 Europe PACS Market by Country
- 5.4 Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 5.4.1 Europe Multi-Department PACS Market by Country
- 5.4.2 Europe Department PACS Market by Country
- 5.4.3 Europe Multi-Site PACS Market by Country
- Chapter 6. Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 6.1 Europe Independent Vendor Market by Country
- 6.2 Europe Third-party Vendor Market by Country
- Chapter 7. Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 7.1 Europe On-Premise Market by Country
- 7.2 Europe Cloud-Based Market by Country
- 7.3 Europe Hybrid Model Market by Country
- Chapter 8. Europe Vendor Neutral Archive (VNA) & PACS Market by End User
- 8.1 Europe Hospitals & Clinics Market by Country
- 8.2 Europe Diagnostic Centers Market by Country
- 8.3 Europe Others Market by Country
- Chapter 9. Europe Vendor Neutral Archive (VNA) & PACS Market by Application
- 9.1 Europe Cardiology Market by Country
- 9.2 Europe Orthopedic Market by Country
- 9.3 Europe Oncology Market by Country
- 9.4 Europe Neurology Market by Country
- 9.5 Europe Obstetrics & Gynecology Market by Country
- 9.6 Europe Others Market by Country
- Chapter 10. Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
- 10.1 Europe Computed Tomography Market by Country
- 10.2 Europe Mammography Market by Country
- 10.3 Europe MRI Market by Country
- 10.4 Europe Ultrasound Market by Country
- 10.5 Europe X-Rays Market by Country
- 10.6 Europe PET Market by Country
- Chapter 11. Europe Vendor Neutral Archive (VNA) & PACS Market by Country
- 11.1 Germany Vendor Neutral Archive (VNA) & PACS Market
- 11.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.1.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.1.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.1.3 Germany Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.1.4 Germany Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.1.5 Germany Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.1.6 Germany Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.2 UK Vendor Neutral Archive (VNA) & PACS Market
- 11.2.1 UK Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.2.1.1 UK Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.2.1.2 UK Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.2.2 UK Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.2.3 UK Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.2.4 UK Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.2.5 UK Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.2.6 UK Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.3 France Vendor Neutral Archive (VNA) & PACS Market
- 11.3.1 France Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.3.1.1 France Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.3.1.2 France Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.3.2 France Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.3.3 France Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.3.4 France Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.3.5 France Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.3.6 France Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.4 Russia Vendor Neutral Archive (VNA) & PACS Market
- 11.4.1 Russia Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.4.1.1 Russia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.4.1.2 Russia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.4.2 Russia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.4.3 Russia Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.4.4 Russia Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.4.5 Russia Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.4.6 Russia Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.5 Spain Vendor Neutral Archive (VNA) & PACS Market
- 11.5.1 Spain Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.5.1.1 Spain Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.5.1.2 Spain Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.5.2 Spain Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.5.3 Spain Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.5.4 Spain Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.5.5 Spain Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.5.6 Spain Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.6 Italy Vendor Neutral Archive (VNA) & PACS Market
- 11.6.1 Italy Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.6.1.1 Italy Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.6.1.2 Italy Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.6.2 Italy Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.6.3 Italy Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.6.4 Italy Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.6.5 Italy Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.6.6 Italy Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.7 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market
- 11.7.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.7.1.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.7.1.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.7.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.7.3 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.7.4 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.7.5 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.7.6 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
- Chapter 12. Company Profiles
- 12.1 Hyland Software, Inc.
- 12.1.1 Company Overview
- 12.1.2 Recent strategies and developments:
- 12.1.2.1 Partnerships, Collaborations, and Agreements:
- 12.1.2.2 Product Launches and Product Expansions:
- 12.2 GE HealthCare Technologies, Inc.
- 12.2.1 Company Overview
- 12.2.2 Financial Analysis
- 12.2.3 Segmental and Regional Analysis
- 12.2.4 Research & Development Expenses
- 12.2.5 Recent strategies and developments:
- 12.2.5.1 Partnerships, Collaborations, and Agreements:
- 12.2.6 SWOT Analysis
- 12.3 Koninklijke Philips N.V.
- 12.3.1 Company Overview
- 12.3.2 Financial Analysis
- 12.3.3 Segmental and Regional Analysis
- 12.3.4 Research & Development Expense
- 12.3.5 Recent strategies and developments:
- 12.3.5.1 Partnerships, Collaborations, and Agreements:
- 12.3.6 SWOT Analysis
- 12.4 Siemens Healthineers AG (Siemens AG)
- 12.4.1 Company Overview
- 12.4.2 Financial Analysis
- 12.4.3 Segmental and Regional Analysis
- 12.4.4 Research & Development Expense
- 12.4.5 Recent strategies and developments:
- 12.4.5.1 Partnerships, Collaborations, and Agreements:
- 12.4.6 SWOT Analysis
- 12.5 Fujifilm Holdings Corporation
- 12.5.1 Company Overview
- 12.5.2 Financial Analysis
- 12.5.3 Segmental and Regional Analysis
- 12.5.4 Research & Development Expenses
- 12.5.5 Recent strategies and developments:
- 12.5.5.1 Product Launches and Product Expansions:
- 12.5.5.2 Acquisition and Mergers:
- 12.5.6 SWOT Analysis
- 12.6 IBM Corporation
- 12.6.1 Company Overview
- 12.6.2 Financial Analysis
- 12.6.3 Regional & Segmental Analysis
- 12.6.4 Research & Development Expenses
- 12.6.5 Recent strategies and developments:
- 12.6.5.1 Product Launches and Product Expansions:
- 12.6.6 SWOT Analysis
- 12.7 Carestream Health, Inc. (Onex Corporation)
- 12.7.1 Company Overview
- 12.7.2 SWOT Analysis
- 12.8 Novarad Enterprise Healthcare Solutions
- 12.8.1 Company Overview
- 12.8.2 Recent strategies and developments:
- 12.8.2.1 Partnerships, Collaborations, and Agreements:
- 12.8.2.2 Product Launches and Product Expansions:
- 12.8.3 SWOT Analysis
- 12.9 Canon, Inc. (Canon Medical Systems Corporation)
- 12.9.1 Company Overview
- 12.9.2 Financial Analysis
- 12.9.3 Segmental and Regional Analysis
- 12.9.4 Research & Development Expenses
- 12.9.5 Recent strategies and developments:
- 12.9.5.1 Partnerships, Collaborations, and Agreements:
- 12.9.5.2 Product Launches and Product Expansions:
- 12.9.6 SWOT Analysis
- 12.10. INFINITT Healthcare Co. Ltd.
- 12.10.1 Company Overview
- 12.10.2 Recent strategies and developments:
- 12.10.2.1 Partnerships, Collaborations, and Agreements:
- 12.10.2.2 Product Launches and Product Expansions:
- 12.10.3 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.